Andrew David Wilcock, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitals | 6 | 2022 | 3290 | 0.850 |
Why?
|
Medicare | 9 | 2022 | 5691 | 0.820 |
Why?
|
Reperfusion | 1 | 2021 | 290 | 0.780 |
Why?
|
Economics, Hospital | 1 | 2021 | 198 | 0.760 |
Why?
|
Transportation | 1 | 2020 | 210 | 0.680 |
Why?
|
Reimbursement Mechanisms | 2 | 2021 | 665 | 0.670 |
Why?
|
Subacute Care | 1 | 2020 | 152 | 0.660 |
Why?
|
Telemedicine | 7 | 2022 | 2583 | 0.650 |
Why?
|
Medicare Part C | 2 | 2020 | 240 | 0.630 |
Why?
|
Reimbursement, Incentive | 1 | 2021 | 525 | 0.600 |
Why?
|
Arthroplasty, Replacement | 1 | 2020 | 323 | 0.580 |
Why?
|
Ischemic Attack, Transient | 2 | 2021 | 895 | 0.570 |
Why?
|
Marketing of Health Services | 1 | 2016 | 156 | 0.550 |
Why?
|
Stroke | 5 | 2022 | 9256 | 0.510 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2021 | 1331 | 0.480 |
Why?
|
Rural Population | 2 | 2020 | 2130 | 0.460 |
Why?
|
Cachexia | 1 | 2013 | 181 | 0.450 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 712 | 0.420 |
Why?
|
Patient Readmission | 2 | 2021 | 2952 | 0.390 |
Why?
|
Palliative Care | 5 | 2020 | 3261 | 0.390 |
Why?
|
Drug-Eluting Stents | 1 | 2016 | 735 | 0.370 |
Why?
|
Electric Stimulation Therapy | 1 | 2013 | 624 | 0.320 |
Why?
|
Brain Ischemia | 1 | 2021 | 3260 | 0.310 |
Why?
|
Exercise Therapy | 1 | 2013 | 901 | 0.300 |
Why?
|
Quality of Health Care | 1 | 2021 | 4266 | 0.300 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1521 | 0.270 |
Why?
|
Healthcare Disparities | 1 | 2020 | 2996 | 0.270 |
Why?
|
United States | 17 | 2022 | 67165 | 0.270 |
Why?
|
Mass Media | 2 | 2018 | 315 | 0.270 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1851 | 0.260 |
Why?
|
Insurance Claim Review | 2 | 2018 | 736 | 0.230 |
Why?
|
Urban Population | 2 | 2020 | 2006 | 0.220 |
Why?
|
Patient-Centered Care | 3 | 2020 | 1446 | 0.200 |
Why?
|
Hospitals, Rural | 1 | 2022 | 152 | 0.200 |
Why?
|
Aged | 16 | 2022 | 161488 | 0.190 |
Why?
|
Rehabilitation | 1 | 2020 | 133 | 0.180 |
Why?
|
Physicians | 1 | 2016 | 4292 | 0.170 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4969 | 0.170 |
Why?
|
Patient Discharge | 2 | 2021 | 2980 | 0.170 |
Why?
|
Coronavirus | 1 | 2020 | 146 | 0.170 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2018 | 1161 | 0.160 |
Why?
|
Exercise | 1 | 2013 | 5251 | 0.160 |
Why?
|
Health Care Sector | 1 | 2018 | 194 | 0.150 |
Why?
|
Advance Care Planning | 2 | 2020 | 611 | 0.150 |
Why?
|
Insurance Coverage | 2 | 2018 | 1847 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 4865 | 0.140 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2163 | 0.130 |
Why?
|
Treatment Outcome | 1 | 2021 | 61932 | 0.130 |
Why?
|
Patient Transfer | 1 | 2021 | 759 | 0.130 |
Why?
|
Multiple Sclerosis | 2 | 2020 | 2934 | 0.130 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 2129 | 0.130 |
Why?
|
Neoplasms | 3 | 2020 | 20172 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58184 | 0.120 |
Why?
|
Humans | 26 | 2022 | 708843 | 0.120 |
Why?
|
Hospital Administration | 1 | 2016 | 329 | 0.120 |
Why?
|
Health Status Indicators | 1 | 2018 | 987 | 0.120 |
Why?
|
Neurology | 1 | 2020 | 732 | 0.110 |
Why?
|
Psychiatry | 2 | 2021 | 1597 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 934 | 0.110 |
Why?
|
Patient Participation | 1 | 2020 | 1447 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2013 | 12183 | 0.090 |
Why?
|
Hormones | 1 | 2013 | 855 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1343 | 0.090 |
Why?
|
Male | 12 | 2021 | 349524 | 0.080 |
Why?
|
Immune System | 1 | 2013 | 806 | 0.080 |
Why?
|
Dyspnea | 1 | 2015 | 1237 | 0.080 |
Why?
|
Female | 12 | 2021 | 375205 | 0.080 |
Why?
|
Psychometrics | 1 | 2016 | 2966 | 0.080 |
Why?
|
Emotions | 1 | 2018 | 2413 | 0.080 |
Why?
|
Health Expenditures | 1 | 2019 | 2240 | 0.070 |
Why?
|
Pandemics | 2 | 2022 | 7089 | 0.070 |
Why?
|
Mental Health | 1 | 2018 | 2602 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2018 | 4988 | 0.060 |
Why?
|
Hospitalization | 2 | 2020 | 9644 | 0.060 |
Why?
|
Middle Aged | 9 | 2021 | 213752 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3308 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4165 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2020 | 4810 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7487 | 0.060 |
Why?
|
Mental Disorders | 1 | 2021 | 6395 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3153 | 0.050 |
Why?
|
Slovenia | 1 | 2020 | 7 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 41038 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3275 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 11594 | 0.050 |
Why?
|
Belgium | 1 | 2020 | 98 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 16008 | 0.050 |
Why?
|
Advance Directives | 1 | 2020 | 227 | 0.050 |
Why?
|
Italy | 1 | 2020 | 744 | 0.040 |
Why?
|
Denmark | 1 | 2020 | 713 | 0.040 |
Why?
|
Adaptation, Psychological | 2 | 2020 | 2565 | 0.040 |
Why?
|
Episode of Care | 1 | 2019 | 117 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2021 | 572 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 39292 | 0.040 |
Why?
|
Adult | 6 | 2021 | 211041 | 0.040 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2016 | 72 | 0.040 |
Why?
|
Netherlands | 1 | 2020 | 2068 | 0.040 |
Why?
|
Censuses | 1 | 2017 | 184 | 0.040 |
Why?
|
Multiple System Atrophy | 1 | 2016 | 84 | 0.040 |
Why?
|
Private Sector | 1 | 2018 | 390 | 0.040 |
Why?
|
Heart Failure | 1 | 2018 | 10040 | 0.030 |
Why?
|
Sample Size | 1 | 2018 | 821 | 0.030 |
Why?
|
Self Efficacy | 1 | 2018 | 629 | 0.030 |
Why?
|
Inflammation | 1 | 2013 | 10019 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 23020 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 55940 | 0.030 |
Why?
|
Health Services Research | 1 | 2020 | 1836 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15252 | 0.030 |
Why?
|
Europe | 1 | 2018 | 3104 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2018 | 71483 | 0.030 |
Why?
|
Australia | 1 | 2015 | 1276 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2017 | 862 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2016 | 13536 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2536 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 1906 | 0.020 |
Why?
|
Cost of Illness | 1 | 2018 | 1820 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6257 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2732 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 84718 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3455 | 0.020 |
Why?
|
Decision Making | 1 | 2020 | 3802 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 8992 | 0.020 |
Why?
|
Insurance, Health | 1 | 2017 | 2475 | 0.020 |
Why?
|
Medicaid | 1 | 2017 | 2613 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13298 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2016 | 2578 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13468 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7428 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 11877 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3014 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19423 | 0.010 |
Why?
|
Child | 1 | 2018 | 73636 | 0.010 |
Why?
|